Advancements in Molecular Diagnosis and Pharmacotherapeutic Strategies for Invasive Pituitary Adenomas
2024

Advancements in Diagnosis and Treatment of Invasive Pituitary Adenomas

publication Evidence: moderate

Author Information

Author(s): Xu Dingkai, Wang Ling, Zheng Maohua

Primary Institution: The First Hospital of Lanzhou University

Hypothesis

The study aims to improve the diagnostic criteria and treatment strategies for invasive pituitary adenomas (IPAs).

Conclusion

The review highlights the need for a comprehensive approach to diagnose and treat IPAs, integrating various diagnostic methods and therapeutic strategies.

Supporting Evidence

  • Pituitary adenomas are the most common type of pituitary tumor, affecting about 1 in 1000 people.
  • Current diagnostic methods for invasive pituitary adenomas often lack sensitivity and specificity.
  • Surgical resection is the primary treatment, but complete removal is achieved in only 66%-78% of cases.

Takeaway

This study talks about how doctors can better find and treat certain brain tumors called invasive pituitary adenomas, which can be tricky to deal with.

Methodology

The article reviews existing literature on diagnostic criteria and treatment options for invasive pituitary adenomas, focusing on imaging, pathology, and molecular biology.

Limitations

The study notes the lack of a unified standard for defining and diagnosing IPAs, which complicates treatment.

Digital Object Identifier (DOI)

10.1002/iid3.70098

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication